02 03 Inside HSCA: HSCA, Avalere Health Report Details Critical Role of GPOs in Mitigating Impact of Prescription Drug Shortages 04 05 15 16 19 20 21 22 23 24 25 26 27 28 31 32 33

HSCA, Avalere Health Report Details Critical Role of GPOs in Mitigating Impact of Prescription Drug Shortages

34
A new report from Avalere Health and the Healthcare Supply Chain Association (HSCA) called The Vital Role of Group Purchasing Organizations in Alleviating Drug Shortages in the United States found that healthcare group purchasing organizations (GPOs) play a significant role in helping hospitals, purchasing partners and suppliers alleviate the impact of prescription drug shortages in the United States.

In its report, Avalere found that GPOs are taking a variety of specific steps to help mitigate the impact of drug shortages, including:

Avalere also identified specific policy recommendations for a multi-stakeholder approach to combat drug shortages, including:

The drug shortage report also includes a number of case studies illustrating the strategies employed by GPOs to expand production capacity for drugs in short supply and to ensure the timely reporting of shortages. GPO strategies depicted in the case studies include:

“Drug shortages are a complex problem with no overnight fix,” said HSCA President Curtis Rooney. “GPOs are committed to continuing to work with government, industry, hospitals, and all supply chain stakeholders to find a solution to this public health crisis.”

To read the complete Avalere/HSCA report, The Vital Role of Group Purchasing Organizations in Alleviating Drug Shortages in the United States, please click here or visit the HSCA website at www.supplychainassociation.org.

For more information about the efforts of GPOs to help mitigate the impact of drug shortages, please visit www.drugshortage.org.

For the full HSCA press release, click here.
35 36 37 38